The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 4, 2000, Pages 533-537

  Semaan, Husam B ^a   Gurbel, Paul A ^b   Anderson, Jeffrey L ^c   Muhlestein, Joseph B ^c   Carlquist, John F ^c   Horne, Benjamin D ^c   Serebruany, Victor L ^b,d  

^a UNION MEMORIAL HOSPITAL   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

Author keywords

Azithromycin; Chlamydia pneumoniae; Coronary artery disease; E Selectin; ICAM 1; VCAM 1

Indexed keywords

AZITHROMYCIN; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; INFLAMMATORY CELL; MALE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0033801750     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200010000-00018     Document Type: Article

References (31)

1. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
2. Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease
3. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese
4. Chlamydia pneumoniae (TWAR)
5. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
6. Induction of macrophage foam cell formation by Chlamydia pneumoniae
7. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity
8. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis
9. Is atherosclerosis an infectious disease?
10. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
11. Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease
12. Circulating adhesion molecules in cystic fibrosis
13. Soluble vascular cell adhesion molecule- 1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents
14. Plasma soluble intracellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina
15. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid athero-sclerosis and incident coronary heart disease cases
16. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
17. Concurrent gonococcal and chlamydial infection: How best to treat
18. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: A prospective, randomized, multicenter trial
19. Infection with Chlamydia pneumoniae accelerated the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
20. Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1
21. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
22. Treatment with antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS study
23. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
24. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
25. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (stray grading) of associated atherosclerotic plaques
26. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study
27. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
28. Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease
29. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: Population based study of coronary heart disease
30. Antibiotic treatment trials for secondary prevention of coronary artery disease events